Expression of Antioxidant Molecules and Heat Shock Protein 27 in Thyroid Tumors

Journal of Cellular Biochemistry

Volumn , Issue , 2016, Pages 2473-2481

  Wang, Shanshan ^a   Yang, Shucui ^a   Vlantis, Alexander C ^a   Liu, Shirley Y W ^a   Ng, Enders K W ^a   Chan, Amy B W ^b   Wu, Juekun ^c   Du, Jing ^d   Wei, Wei ^d   Liu, Xiaoling ^d   Liu, Zhimin ^e   Ng, Siu Kwan ^a   van Hasselt, C Andrew ^a   Tong, Michael C F ^a   Chen, George G ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^e CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

27 kd HEAT SHOCK PROTEIN; ANTIOXIDANTS; OXIDANTS; THYROID TUMORS

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEAT SHOCK PROTEIN 27; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE 2;

ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NODULAR GOITER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CANCER; THYROID CARCINOMA; THYROID CELL; THYROID FOLLICULAR CARCINOMA; THYROID GLAND TISSUE; THYROID TUMOR; UPREGULATION; WESTERN BLOTTING;

EID: 84986209206     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25539     Document Type: Article

References (33)

1. Akinci M, Kosova F, Cetin B, Sepici A, Altan N, Aslan S, Cetin A. 2008. Oxidant/antioxidant balance in patients with thyroid cancer. Acta Cir Bras 23:551–554.
2. Bausero MA, Bharti A, Page DT, Perez KD, Eng JW, Ordonez SL, Asea EE, Jantschitsch C, Kindas-Muegge I, Ciocca D, et al. 2006. Silencing the hsp25 gene eliminates migration capability of the highly metastatic murine 4T1 breast adenocarcinoma cell. Tumour Biol 27:17–26.
3. Chen GG, Lai PB, Chak EC, Xu H, Lee KM, Lau WY. 2001. Immunohistochemical analysis of pro-apoptotic bid level in chronic hepatitis, hepatocellular carcinoma and liver metastases. Cancer Lett 172:75–82.
4. Ciocca DR, Calderwood SK. 2005. Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86–103.
5. Eggo MC. 2010. Molecular regulation of thyroid gland function. Curr Opin Endocrinol Diabetes Obes 17:396–401.
6. Gibert B, Eckel B, Gonin V, Goldschneider D, Fombonne J, Deux B, Mehlen P, Arrigo AP, Clezardin P, Diaz-Latoud C. 2012. Targeting heat shock protein 27 (HspB1) interferes with bone metastasis and tumour formation in vivo. Br J Cancer 107:63–70.
7. Grzegrzolka J, Kurnol K, Piotrow P, Pula B, Kobierzycki C, Piotrowska A, Jablonska K, Wojnar A, Rys J, Dziegiel P, et al. 2012. Hsp-27 expression in invasive ductal breast carcinoma. Folia Histochem Cytobiol 50:527–533.
8. Hansen RK, Parra I, Lemieux P, Oesterreich S, Hilsenbeck SG, Fuqua SA. 1999. Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat 56:187–196.
9. Kanazawa Y, Isomoto H, Oka M, Yano Y, Soda H, Shikuwa S, Takeshima F, Omagari K, Mizuta Y, Murase K, et al. 2003. Expression of heat shock protein (Hsp) 70 and Hsp 40 in colorectal cancer. Med Oncol 20:157–164.
10. Khalid H, Tsutsumi K, Yamashita H, Kishikawa M, Yasunaga A, Shibata S. 1995. Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions. Cell Mol Neurobiol 15:257–268.
11. Laatikainen LE, Castellone MD, Hebrant A, Hoste C, Cantisani MC, Laurila JP, Salvatore G, Salerno P, Basolo F, Nasman J, et al. 2010. Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer. Endocr Relat Cancer 17:785–796.
12. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. 2007. Prognostic factors in papillary and follicular thyroid carcinoma: Their implications for cancer staging. Ann Surg Oncol 14:730–738.
13. Lang BH, Lo CY, Wong KP, Wan KY. 2013. Should an involved but functioning recurrent laryngeal nerve be shaved or resected in a locally advanced papillary thyroid carcinoma? Ann Surg Oncol 20:2951–2957.
14. Lee SA, Ndisang D, Patel C, Dennis JH, Faulkes DJ, D'Arrigo C, Samady L, Farooqui-Kabir S, Heads RJ, Latchman DS, et al. 2005. Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in breast cancer biopsies and is required for maximal activation of the HSP-27 promoter. Cancer Res 65:3072–3080.
15. Li X, Wang Z, Liu J, Tang C, Duan C, Li C. 2012. Proteomic analysis of differentially expressed proteins in normal human thyroid cells transfected with PPFP. Endocr Relat Cancer 19:681–694.
16. Lin JC, Kuo WR, Chiang FY, Hsiao PJ, Lee KW, Wu CW, Juo SH. 2009. Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer. Surgery 145:508–513.
17. Madamanchi NR, Li S, Patterson C, Runge MS. 2001. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler Thromb Vasc Biol 21:321–326.
18. Mendes F, Sales T, Domingues C, Schugk S, Abrantes AM, Goncalves AC, Teixo R, Silva R, Casalta-Lopes J, Rocha C, et al. 2015. Effects of X-radiation on lung cancer cells: The interplay between oxidative stress and P53 levels. Med Oncol 32:266.
19. Meyer Y, Buchanan BB, Vignols F, Reichheld JP. 2009. Thioredoxins and glutaredoxins: Unifying elements in redox biology. Annu Rev Genet 43:335–367.
20. Nagababu E, Chrest FJ, Rifkind JM. 2003. Hydrogen-peroxide-induced heme degradation in red blood cells: The protective roles of catalase and glutathione peroxidase. Biochim Biophys Acta 1620:211–217.
21. Nishida S, Akai F, Iwasaki H, Hosokawa K, Kusunoki T, Suzuki K, Taniguchi N, Hashimoto S, Tamura TT. 1993. Manganese superoxide dismutase content and localization in human thyroid tumours. J Pathol 169:341–345.
22. Partida-Rodriguez O, Torres J, Flores-Luna L, Camorlinga M, Nieves-Ramirez M, Lazcano E, Perez-Rodriguez M. 2010. Polymorphisms in TNF and HSP-70 show a significant association with gastric cancer and duodenal ulcer. Int J Cancer 126:1861–1868.
23. Pinthus JH, Bryskin I, Trachtenberg J, Lu JP, Singh G, Fridman E, Wilson BC. 2007. Androgen induces adaptation to oxidative stress in prostate cancer: Implications for treatment with radiation therapy. Neoplasia 9:68–80.
24. Romanucci M, Bastow T, Della-Salda L. 2008. Heat shock proteins in animal neoplasms and human tumours—A comparison. Cell Stress Chaperones 13:253–262.
25. Saiselet M, Floor S, Tarabichi M, Dom G, Hebrant A, van Staveren WC, Maenhaut C. 2012. Thyroid cancer cell lines: An overview. Front Endocrinol (Lausanne) 3:133.
26. Senthil N, Manoharan S. 2004. Lipid peroxidation and antioxidants status in patients with papillary thyroid carcinoma in India. Asia Pac J Clin Nutr 13:391–395.
27. Siegel R, Ma J, Zou Z, Jemal A. 2014. Cancer statistics, 2014. CA Cancer J Clin 64:9–29.
28. Storm FK, Mahvi DM, Gilchrist KW. 1996. Lack of association between tumor necrosis and hsp-27 expression in primary breast cancer. J Surg Oncol 61:14–16.
29. Thanner F, Sutterlin MW, Kapp M, Rieger L, Kristen P, Dietl J, Gassel AM, Muller T. 2003. Heat-shock protein 70 as a prognostic marker in node-negative breast cancer. Anticancer Res 23:1057–1062.
30. Tsutsumi S, Beebe K, Neckers L. 2009. Impact of heat-shock protein 90 on cancer metastasis. Future Oncol 5:679–688.
31. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. 2006. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40.
32. Weber G, Rabbiosi S, Zamproni I, Fugazzola L. 2013. Genetic defects of hydrogen peroxide generation in the thyroid gland. J Endocrinol Invest 36:261–266.
33. Wedgwood S, Lakshminrusimha S, Fukai T, Russell JA, Schumacker PT, Steinhorn RH. 2011. Hydrogen peroxide regulates extracellular superoxide dismutase activity and expression in neonatal pulmonary hypertension. Antioxid Redox Signal 15:1497–1506.